Evidence map›Paper›PMID 38088972›Full record

ArticleFrontiers in microbiology2023

Efficacy and safety of fecal microbiota transplantation for chronic insomnia in adults: a real world study.

Haiming Fang, Tingting Yao, Wanli Li, Na Pan, Hang Xu, Qian Zhao, Yuan Su, Kangwei Xiong, Jiajia Wang

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06606938 (Faecal Microbiota Transplantation for Insomnia Disorder), which is not on this map. Cited by 27 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 3 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06606938 nanot yet recruitingnot on this mapstarted 2024, after this paper: background citation

Faecal Microbiota Transplantation for Insomnia Disorder: a Randomized, Double-blind, Placebo-controlled Trial

TypeinterventionalSponsorChinese University of Hong KongRan2024 to 2027Enrolled74ConditionsChronic Insomnia DisorderArmsFaecal Microbiota Transplantation, Normal Saline (Placebo)
3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 3 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Increased relative abundance ofFrontiers in sleep · 2025
    Article
  19. Microbiome-Based Therapeutics for Insomnia.International journal of molecular sciences · 2024
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Haiming FangDepartment of Gastroenterology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Tingting YaoDepartment of Gastroenterology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Wanli LiDepartment of Pharmacology, School of Basic Medical Sciences of Anhui Medical University, Hefei, Anhui, China.
Na PanDepartment of Pharmacology, School of Basic Medical Sciences of Anhui Medical University, Hefei, Anhui, China.
Hang XuSchool of Medicine, Anhui University of Science and Technology, Huainan, Anhui, China.
Qian ZhaoDepartment of Gastroenterology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Yuan SuDepartment of Gastroenterology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Kangwei XiongDepartment of Gastroenterology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Jiajia WangDepartment of Pharmacology, School of Basic Medical Sciences of Anhui Medical University, Hefei, Anhui, China.
Anhui Medical University · CNSecond Affiliated Hospital of Anhui Medical University · CNAnhui University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To assess the efficacy and safety of fecal microbiota transplantation (FMT) for adult chronic insomnia. Methods: Patients treated with FMT for chronic diseases were divided into chronic insomnia and non-insomnia group. The primary endpoint was the efficacy of FMT for insomnia 4 weeks after treatment, the secondary endpoints included the impacts of FMT on anxiety, depression, health-related quality of life, gut microbiota, and adverse events associated with FMT. Insomnia Severity Index (ISI) and Pittsburgh Sleep Quality Index (PSQI) were utilized to assess the efficacy of FMT on insomnia, self-rating anxiety/depression scale [Zung Self-Rating Anxiety Scale (SAS), Zung Self-Rating Depression Scale (SDS)] was employed to evaluate anxiety and depression. Quality of life was evaluated by SF-36. 16S rRNA sequencing was employed to analyze the gut microbiota and correlation analysis was performed. Results: Forty patients met the inclusion criteria and seven were excluded. 33 patients were enrolled and stratified into chronic insomnia group ( Conclusion:

Indexed as

brain-gut axischronic insomniadysbiosisfecal microbiota transplantationgut microbiota

Identifiers

PMID38088972
PMCPMC10712199
OpenAlexW4388941262

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.